9-2729475-C-T

Variant names:

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_133497.4(KCNV2):c.1386C>T(p.Asp462Asp) variant causes a synonymous change. The variant allele was found at a frequency of 0.0703 in 1,613,786 control chromosomes in the GnomAD database, including 4,479 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.063 ( 388 hom., cov: 32)

Exomes 𝑓: 0.071 ( 4091 hom. )

Consequence

KCNV2
NM_133497.4 synonymous

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.07

Publications

7 publications found

Variant links:

Genes affected

KCNV2 (HGNC:19698): (potassium voltage-gated channel modifier subfamily V member 2) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium voltage-gated channel subfamily V. This member is identified as a 'silent subunit', and it does not form homomultimers, but forms heteromultimers with several other subfamily members. Through obligatory heteromerization, it exerts a function-altering effect on other potassium channel subunits. This protein is strongly expressed in pancreas and has a weaker expression in several other tissues. [provided by RefSeq, Jul 2008]

KCNV2 links:

PUM3 (HGNC:29676): (pumilio RNA binding family member 3) Enables RNA binding activity. Involved in regulation of protein ADP-ribosylation. Located in chromosome; endoplasmic reticulum; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]

PUM3 links:

ENSG00000286670 (HGNC:):

ENSG00000286670 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.28).

BP6

Variant 9-2729475-C-T is Benign according to our data. Variant chr9-2729475-C-T is described in ClinVar as [Benign]. Clinvar id is 262359.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BA1

GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0925 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
KCNV2	NM_133497.4 link	c.1386C>T	p.Asp462Asp	synonymous_variant	Exon 2 of 2	ENST00000382082.4	NP_598004.1	Q8TDN2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
KCNV2	ENST00000382082.4 link	c.1386C>T	p.Asp462Asp	synonymous_variant	Exon 2 of 2	1	NM_133497.4	ENSP00000371514.3		Q8TDN2

Frequencies

GnomAD3 genomes

AF:

0.0631

AC:

9606

AN:

152134

Hom.:

390

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0339

Gnomad AMI

AF:

0.0844

Gnomad AMR

AF:

0.0965

Gnomad ASJ

AF:

0.110

Gnomad EAS

AF:

0.0243

Gnomad SAS

AF:

0.0460

Gnomad FIN

AF:

0.0703

Gnomad MID

AF:

0.0127

Gnomad NFE

AF:

0.0740

Gnomad OTH

AF:

0.0646

GnomAD2 exomes

AF:

0.0745

AC:

18738

AN:

251370

AF XY:

0.0705

show subpopulations

Gnomad AFR exome

AF:

0.0338

Gnomad AMR exome

AF:

0.143

Gnomad ASJ exome

AF:

0.108

Gnomad EAS exome

AF:

0.0241

Gnomad FIN exome

AF:

0.0742

Gnomad NFE exome

AF:

0.0724

Gnomad OTH exome

AF:

0.0736

GnomAD4 exome

AF:

0.0710

AC:

103778

AN:

1461534

Hom.:

4091

Cov.:

AF XY:

0.0697

AC XY:

50692

AN XY:

727080

show subpopulations

African (AFR)

AF:

0.0325

AC:

1086

AN:

33464

American (AMR)

AF:

0.137

AC:

6108

AN:

44720

Ashkenazi Jewish (ASJ)

AF:

0.105

AC:

2746

AN:

26132

East Asian (EAS)

AF:

0.0215

AC:

855

AN:

39700

South Asian (SAS)

AF:

0.0458

AC:

3946

AN:

86240

European-Finnish (FIN)

AF:

0.0768

AC:

4104

AN:

53420

Middle Eastern (MID)

AF:

0.0262

AC:

148

AN:

5648

European-Non Finnish (NFE)

AF:

0.0726

AC:

80682

AN:

1111830

Other (OTH)

AF:

0.0680

AC:

4103

AN:

60380

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.463

Heterozygous variant carriers

5499

10998

16496

21995

27494

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

GnomAD4 genome

AF:

0.0631

AC:

9604

AN:

152252

Hom.:

388

Cov.:

AF XY:

0.0620

AC XY:

4618

AN XY:

74448

show subpopulations

African (AFR)

AF:

0.0339

AC:

1407

AN:

41552

American (AMR)

AF:

0.0966

AC:

1478

AN:

15298

Ashkenazi Jewish (ASJ)

AF:

0.110

AC:

380

AN:

3468

East Asian (EAS)

AF:

0.0241

AC:

125

AN:

5178

South Asian (SAS)

AF:

0.0461

AC:

222

AN:

4820

European-Finnish (FIN)

AF:

0.0703

AC:

745

AN:

10604

Middle Eastern (MID)

AF:

0.00680

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.0740

AC:

5036

AN:

68014

Other (OTH)

AF:

0.0625

AC:

132

AN:

2112

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.500

Heterozygous variant carriers

446

892

1339

1785

2231

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Alfa

AF:

0.0732

Hom.:

244

Bravo

AF:

0.0647

Asia WGS

AF:

0.0360

AC:

127

AN:

3478

EpiCase

AF:

0.0694

EpiControl

AF:

0.0634

ClinVar

Significance: Benign

Submissions summary: Benign:4

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Benign:2

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Breakthrough Genomics, Breakthrough Genomics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:not provided

- -

not specified

Benign:1

PreventionGenetics, part of Exact Sciences

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Cone dystrophy with supernormal rod response

Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.28

CADD

Benign

9.6

(source)

DANN

Benign

0.82

PhyloP100

4.1

Mutation Taster

=95/5

polymorphism (auto)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

9-2729475-C-T

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over